In the DAPA-CKD trial, treatment with the SGLT2 inhibitor dapagliflozin reduced risk for worsening renal function and death due to CVD or renal disease in patients with chronic kidney disease, both with and without type 2 diabetes. Hiddo J.L. Heerspink.
See Original Article

Abbott Laboratories has trials underway for its rapid coronavirus test to determine whether it could effectively be used on asymptomatic people, CEO Robert Ford told CNBC. Abbott received emergency approval from the FDA this week, but only for use within …
See Original Article

If that happens, the Federal Reserve may not increase interest rates as frequently. Inflation measures how quickly (or not) the price of goods and services grows, while the interest rate a lender uses to charge a borrower is often based on the Federal Reserve’s …
See Original Article

Pandemic continues to impact accountant, CPA work [Cleveland Jewish News] … CPAs Give Lenders More Virus Relief Loan Accounting Guidance
See Original Article

Bloomberg's Michael Barr, Jason Kelly and Mike Lynch also spoke with Jason Wright, President of the NFL's Washington Football team about the
See Original Article